Publication | Open Access
Dalpiciclib Combined With Pyrotinib and Letrozole in Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer (LORDSHIPS): A Phase Ib Study
23
Citations
22
References
2022
Year
ClinicalTrials.gov, identifier NCT03772353.
| Year | Citations | |
|---|---|---|
Page 1
Page 1